MedPath

湖南百草制药有限公司

Ownership
-
Established
1996-11-15
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

27

NMPA:27

Drug Approvals

Telmisartan Capsules

Product Name
雪咪洛
Approval Number
国药准字H20080188
Approval Date
Apr 15, 2022
NMPA

Diclofenac Sodium Enteric-coated Tablets

Product Name
双氯芬酸钠肠溶片
Approval Number
国药准字H43020654
Approval Date
Jul 24, 2020
NMPA

Vitamin B6 Tablets

Product Name
维生素B6片
Approval Number
国药准字H43020656
Approval Date
Nov 27, 2019
NMPA

Compound Sulfamethoxazole Tablets

Product Name
复方磺胺甲噁唑片
Approval Number
国药准字H43020649
Approval Date
Nov 27, 2019
NMPA

Vitamin B1 Tablets

Product Name
维生素B1片
Approval Number
国药准字H43020655
Approval Date
Nov 27, 2019
NMPA

复方丹参片

Approval Number
国药准字Z43020582
Approval Date
Nov 27, 2019
NMPA

Helicid Tablets

Product Name
豆腐果苷片
Approval Number
国药准字H43021852
Approval Date
Nov 27, 2019
NMPA

Cimetidine Tablets

Product Name
西咪替丁片
Approval Number
国药准字H43020617
Approval Date
Nov 27, 2019
NMPA

Metronidazole Tablets

Product Name
甲硝唑片
Approval Number
国药准字H43020651
Approval Date
Nov 27, 2019
NMPA

Cefradine Tablets

Product Name
头孢拉定片
Approval Number
国药准字H20083659
Approval Date
Jan 2, 2018
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.